Search Results 521-530 of 17042 for monoclonal antibody
Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Giving dendritic cell therapy after ...
The purpose of this study is to determine the prevalence, diagnostic accuracy and predictors of antinueronal antibody positivity in serum and cerebrospinal ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
In late 2024, the FDA also approved the use of a new monoclonal antibody drug that uses a lab-made protein that binds to a specific target on a cancer cell to ...
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...
Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...
Cancer treatment myths: Any truth to these common beliefs? Monoclonal antibody drugs for cancer: How they work · Cancer survival rate: What it means for your ...
Bezlotoxumab, a monoclonal antibody against toxin B was recently approved by the Food and Drug Administration for treatment of CDI in patients at high risk ...
... monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 months. ... antibodies to hepatitis B core antigen [anti-HBc] and/or ...
Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects. Goldenberg DM. David M; Morschhauser ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.